HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Michael J Haller Selected Research
Michael J Haller Research Topics
Disease
86
Type 1 Diabetes Mellitus (Autoimmune Diabetes)
04/2024 - 11/2005
8
Autoimmune Diseases (Autoimmune Disease)
12/2021 - 01/2008
5
Hyperglycemia
01/2019 - 10/2009
4
COVID-19
06/2024 - 01/2021
3
Disease Progression
11/2021 - 10/2017
3
Neoplasms (Cancer)
03/2016 - 01/2007
2
Inflammation (Inflammations)
01/2023 - 10/2009
2
Hyperthyroidism
01/2022 - 11/2021
2
Graves Disease (Basedow Disease)
11/2021 - 01/2014
2
Insulinoma
11/2021 - 01/2021
2
Infections
01/2018 - 01/2017
2
Hypoglycemia (Reactive Hypoglycemia)
10/2016 - 02/2016
2
Body Weight (Weight, Body)
12/2015 - 08/2007
2
Insulin Resistance
08/2011 - 01/2008
1
Glucose Intolerance
01/2023
1
Obesity
01/2023
1
Diabetic Ketoacidosis (Ketoacidosis, Diabetic)
09/2022
1
Thyroiditis
11/2021
1
Hypothyroidism
11/2021
1
Ketosis
11/2021
1
Cysts
09/2021
1
Hyperandrogenism
09/2021
1
Virilism (Virilization)
09/2021
1
Genetic Risk Score
01/2021
1
Albuminuria
10/2019
1
Respiratory Tract Infections (Respiratory Tract Infection)
01/2018
1
Narcolepsy
01/2018
1
Genetic Predisposition to Disease (Genetic Predisposition)
10/2017
1
Type 2 Diabetes Mellitus (MODY)
04/2017
1
Fever (Fevers)
01/2017
1
Heart Arrest (Cardiac Arrest)
03/2016
1
Multiple Sclerosis
03/2016
Drug/Important Bio-Agent (IBA)
29
Insulin (Novolin)
FDA Link
06/2024 - 08/2007
24
Autoantibodies
IBA
07/2023 - 02/2011
17
C-Peptide
IBA
04/2024 - 08/2007
17
Glucose (Dextrose)
FDA Link
Generic
01/2023 - 08/2007
11
Antilymphocyte Serum (Anti-Thymocyte Globulin)
IBA
12/2023 - 12/2008
6
Biomarkers (Surrogate Marker)
IBA
12/2022 - 08/2007
4
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
01/2021 - 10/2009
4
Trypsinogen
IBA
01/2021 - 04/2017
4
Blood Glucose (Blood Sugar)
IBA
08/2020 - 07/2013
4
HLA Antigens (Human Leukocyte Antigens)
IBA
01/2018 - 12/2015
3
Glucagon (Glukagon)
FDA Link
01/2020 - 02/2016
3
Immunomodulating Agents
IBA
01/2015 - 08/2007
2
teplizumab
IBA
04/2024 - 01/2022
2
Abatacept (Orencia)
FDA Link
01/2023 - 01/2022
2
Glutamate Decarboxylase (Decarboxylase, Glutamate)
IBA
12/2022 - 09/2011
2
Glycated Hemoglobin (Glycosylated Hemoglobin)
IBA
12/2022 - 01/2019
2
Zinc Transporter 8
IBA
12/2022 - 01/2021
2
Hemoglobins (Hemoglobin)
IBA
11/2022 - 11/2022
2
Lipase (Acid Lipase)
FDA Link
01/2021 - 01/2020
2
Amylases
FDA Link
01/2021 - 01/2020
2
pegylated granulocyte colony-stimulating factor
IBA
09/2018 - 12/2016
1
Monoclonal Antibodies
IBA
04/2024
1
Hydroxychloroquine (Plaquenil)
FDA Link
Generic
11/2023
1
Insulins
IBA
01/2023
1
Autoantigens
IBA
12/2022
1
Alefacept (Amevive)
FDA Link
01/2022
1
Rituximab (Mabthera)
FDA Link
01/2022
1
Globulins
IBA
12/2021
1
Iodide Peroxidase (Deiodinase)
IBA
11/2021
1
Thyrotropin (Thyroid-Stimulating Hormone)
FDA Link
11/2021
1
A-factor (Streptomyces)
IBA
11/2021
1
thyrotropin-binding inhibitory immunoglobulin
IBA
11/2021
1
Thyroxine (Levothyroxine)
FDA Link
Generic
11/2021
1
Enzymes
IBA
01/2021
1
boldenone undecylenate (Equipoise)
IBA
01/2021
1
Suspensions
IBA
01/2021
1
Pancreatic Elastase (Elastase)
IBA
12/2020
1
golimumab
FDA Link
11/2020
1
Interleukin-18 (Interleukin 18)
IBA
01/2020
1
Interleukin-12 (IL 12)
IBA
01/2020
1
Insulin-Like Peptides
IBA
01/2020
1
Creatinine
IBA
10/2019
1
mesoglycan
IBA
10/2019
1
Albumins
IBA
10/2019
1
Carbohydrates
IBA
01/2019
1
Cyclosporine (Ciclosporin)
FDA Link
Generic
01/2018
1
Immunosuppressive Agents (Immunosuppressants)
IBA
01/2018
1
Vaccines
IBA
01/2018
1
HLA-DQ Antigens (HLA-DQ)
IBA
01/2018
1
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
10/2017
1
Tryptophan (L-Tryptophan)
FDA Link
01/2017
1
Illicit Drugs (Recreational Drugs)
IBA
01/2017
1
Ketones
IBA
01/2017
1
Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
IBA
01/2017
1
Acetaminophen (Paracetamol)
FDA Link
Generic
01/2017
1
Kynurenine
IBA
01/2017
1
DNA (Deoxyribonucleic Acid)
IBA
03/2016
1
Cell-Free Nucleic Acids
IBA
03/2016
Therapy/Procedure
19
Therapeutics
04/2024 - 11/2005
6
Glycemic Control
09/2022 - 01/2008
5
Immunotherapy
04/2024 - 12/2020
2
Ambulatory Care (Outpatient Care)
09/2022 - 01/2021
1
Aftercare (After-Treatment)
01/2023
1
Secondary Prevention
12/2022
1
Conservative Treatment
09/2021
1
Enzyme Replacement Therapy
12/2020
1
Injections
01/2019
1
Artificial Pancreas
01/2018